Branch Medical LLC

Branch Medical LLC, a service-disabled veteran-owned small business based in Ridgefield, Washington, supplies laboratory equipment, analytical instruments, medical diagnostic reagents, and consumables to the Department of Veterans Affairs and the Department of Defense as a prime contractor (100% of recent awards) across 1,945 federal contracts, predominantly delivery orders and purchase orders carrying no set-aside designation. The company is a for-profit Subchapter S corporation with self-certified small disadvantaged business and veteran-owned business designations.

Branch Medical's award footprint is heavily concentrated in clinical laboratory supply chains within VA and DoD medical operations. The Defense Logistics Agency Troop Support Medical dominates the customer base by volume and dollars, accounting for 1,762 awards (96% of awards by count) and $20.5 million in combined potential value — nearly 59% of all dollars across the portfolio. This customer alone drives award velocity: DLA Medical Supply Chain issued more than 1,600 delivery orders for laboratory reagents, diagnostic consumables, and equipment in June, July, August, and September 2026. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 ranks second with 62 awards and $14.5 million potential value. Concentration is extreme — the top two customers represent 96% of recent awards and approximately 61% of combined potential value. Secondary VA facilities (VISN 17, VISN 15, VISN 19, VISN 22) and the Defense Health Agency complete the customer set, with four additional agencies representing the remaining potential value.

Branch Medical competes across two primary vehicles. The largest is indefinite-delivery contract SPE2DE21D0032, under which 1,592 task orders carry $6.6 million in combined potential value — a high-volume, low-touch supply channel. A blanket purchase agreement (36C26021A0032) under VA supplies 52 task orders worth $7.7 million. Both vehicles operate on full-and-open competition with no set-aside designation. A single-award IDIQ with Veterans Integrated Service Network 16 (awarded August 1, 2026) carries a five-year ceiling of $785,848.23 for BioPlex 2200 analyzer systems, reagents, and consumables, with a delivery order ceiling of $157,169.65 through July 31, 2027.

Representative work includes a $359,730 purchase order from the National Institute of Standards and Technology (September 16, 2026) for an ultra-high pressure liquid chromatography quadrupole time-of-flight mass spectrometer with installation and training; a $157,169.65 delivery order from VISN 16 under Executive Order 14398 for BioPlex 2200 analyzer systems, reagents, controls, and calibrators running through July 31, 2027; and a $16,740.10 BPA call from VISN 15 under a service-disabled veteran-owned small business sole-source award for blood bank reagents, laboratory equipment, and related supplies through May 31, 2027. Recurring work includes hundreds of delivery orders from DLA Medical Supply Chain for specialty in vitro diagnostic reagents, hematology platform consumables, centrifuge equipment, refrigeration units, urinalysis and chemistry controls, and microparticle immunoassay instrumentation. The company also holds a $136,280.88 service-disabled veteran-owned small business set-aside purchase order from VISN 16 for ABL 820 service and maintenance extending through June 17, 2031.

Activity has grown sharply: 46 awards in 2022 escalated to 800 in 2025 and 570 in 2026 year-to-date, reflecting accelerated ordering through DLA Medical's supply channels. Sixteen awards (combined potential value $2.8 million) reach completion within the next twenty-four months, presenting modest recompete exposure. The portfolio is almost entirely equipment and consumable supply work — 1,727 awards sit under NAICS 424210 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers), 121 under analytical laboratory instrument manufacturing, and 42 under in vitro diagnostic substance manufacturing. Across the portfolio, $25.7 million has been obligated against $70.8 million in combined potential value (36% obligation rate), typical of indefinite-delivery and blanket-purchase structures with episodic order placement.

Branch Medical an experienced company serving the needs of laboratories equipment, reagent, consumable supply needs. We serve the needs of the reagent contract to support the care of veterans and military service members.